Clinical Trials With Dapagliflozin In Adults Dapagliflozin Dapagliflozin has been evaluated in clinical trials in adult and pediatric patients 10 years of age and older with type 2 diabetes mellitus, in adult patients with heart failure, and in adult patients with chronic kidney disease
This dual mechanism allows Mounjaro to potentially offer stronger effects on both insulin control and appetite regulation
Fifty-seven percent of participants lost at least 20 percent of their body weight
Stress raises cortisol, which promotes fat storage and drives emotional eating
To reduce the risk of side effects and any adverse events from GLP-1 medications, here are some guidelines to keep in mind: Start with a low dose and gradually increase the dose over time Take the medication with meals Eat smaller, more frequent meals Stay well-hydrated Avoid fatty, spicy, or smelly foods if they exacerbate symptoms Consider anti-nausea medications if needed For constipation: Use fiber-rich foods (and over-the-counter laxatives) if needed for constipation Use proper injection technique and rotate injection sites Monitor blood glucose levels regularly, especially if taking other diabetes medications Allergic reactions Although rare, allergic reactions to GLP-1 agonists can occur
